BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17010348)

  • 1. A risk reduction strategy to prevent maternal deaths associated with unsafe abortion.
    Briozzo L; Vidiella G; Rodríguez F; Gorgoroso M; Faúndes A; Pons JE
    Int J Gynaecol Obstet; 2006 Nov; 95(2):221-6. PubMed ID: 17010348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving care of women at risk of unsafe abortion: implementing a risk-reduction model at the Uruguayan-Brazilian border.
    Fiol V; Briozzo L; Labandera A; Recchi V; Piñeyro M
    Int J Gynaecol Obstet; 2012 Sep; 118 Suppl 1():S21-7. PubMed ID: 22840266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unsafe abortion requiring hospital admission in the Eastern Highlands of Papua New Guinea--a descriptive study of women's and health care workers' experiences.
    Vallely LM; Homiehombo P; Kelly-Hanku A; Whittaker A
    Reprod Health; 2015 Mar; 12():22. PubMed ID: 25889957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provision of harm-reduction services to limit unsafe abortion in Tanzania.
    Kahabuka C; Pembe A; Meglioli A
    Int J Gynaecol Obstet; 2017 Feb; 136(2):210-214. PubMed ID: 28099731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of abortion among women admitted to hospitals in Fortaleza, North Eastern Brazil.
    Misago C; Fonseca W; Correia L; Fernandes LM; Campbell O
    Int J Epidemiol; 1998 Oct; 27(5):833-9. PubMed ID: 9839740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing maternal mortality due to elective abortion: Potential impact of misoprostol in low-resource settings.
    Harper CC; Blanchard K; Grossman D; Henderson JT; Darney PD
    Int J Gynaecol Obstet; 2007 Jul; 98(1):66-9. PubMed ID: 17466303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical abortion and manual vacuum aspiration for legal abortion protect women's health and reduce costs to the health system: findings from Colombia.
    Rodriguez MI; Mendoza WS; Guerra-Palacio C; Guzman NA; Tolosa JE
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):125-33. PubMed ID: 25702076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced abortion among Brazilian female sex workers: a qualitative study.
    Madeiro AP; Diniz D
    Cien Saude Colet; 2015 Feb; 20(2):587-93. PubMed ID: 25715152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of medical abortion in the implementation of the law on voluntary termination of pregnancy in Uruguay.
    Fiol V; Rieppi L; Aguirre R; Nozar M; Gorgoroso M; Coppola F; Briozzo L
    Int J Gynaecol Obstet; 2016 Aug; 134(S1):S12-S15. PubMed ID: 28748589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions of misoprostol among providers and women seeking post-abortion care in Zimbabwe.
    Maternowska MC; Mashu A; Moyo P; Withers M; Chipato T
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):16-25. PubMed ID: 25702065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safe abortion information hotlines: An effective strategy for increasing women's access to safe abortions in Latin America.
    Drovetta RI
    Reprod Health Matters; 2015 May; 23(45):47-57. PubMed ID: 26278832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of the risk and harm reduction strategy against unsafe abortion in Uruguay: From a university hospital to the entire country.
    Labandera A; Gorgoroso M; Briozzo L
    Int J Gynaecol Obstet; 2016 Aug; 134 Suppl 1():S7-S11. PubMed ID: 27577026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demographic characteristics of women with self use of misoprostol for pregnancy interruption attending Maharaj Nakorn Chiang Mai Hospital.
    Pongsatha S; Morakot N; Tongsong T
    J Med Assoc Thai; 2002 Oct; 85(10):1074-80. PubMed ID: 12501898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, attitudes and knowledge of misoprostol for self-induction of abortion in women presenting for abortion at Midwestern reproductive health clinics.
    Kerestes C; Sheets K; Stockdale CK; Hardy-Fairbanks AJ
    Sex Reprod Health Matters; 2019 Dec; 27(1):1571311. PubMed ID: 31533561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commercial availability of misoprostol and induced abortion in Brazil.
    Costa SH
    Int J Gynaecol Obstet; 1998 Dec; 63 Suppl 1():S131-9. PubMed ID: 10075223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voluntary Contraceptive Uptake Among Postabortion Care Clients Treated With Misoprostol in Rwanda.
    Packer C; Pack AP; McCarraher DR
    Glob Health Sci Pract; 2019 Aug; 7(Suppl 2):S247-S257. PubMed ID: 31455622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mifepristone-misoprostol midtrimester abortion: impact of gestational age on the induction-to-abortion interval.
    Gómez O; Borrás A; Rabanal A; Palacio M; Carceller A; Coll O; Gratacós E
    Contraception; 2010 Feb; 81(2):97-101. PubMed ID: 20103444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editor's final comment.
    Fortney JA; Sciarra JJ
    Int J Gynaecol Obstet; 2011 Dec; 115(3):298-9. PubMed ID: 21982857
    [No Abstract]   [Full Text] [Related]  

  • 19. Early pregnancy termination with mifepristone and misoprostol in Norway.
    Bjørge L; Johnsen SL; Midbøe G; Augestad G; Økland I; Helland H; Stray-Pedersen S; Iversen OE
    Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1056-61. PubMed ID: 11703208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.